Virtual Reality After Breast Reconstruction Surgery

VR 4 BR: Effects of Virtual Reality on Women Undergoing Mastectomy and Breast Reconstruction, A Pilot Study

This is a pilot study of virtual reality (VR) non-opioid management for women undergoing mastectomy and implant-based reconstruction. Study participants will receive specialized VR interventions, administered via VR headsets, to manage pain.

The primary objective of this study is to estimate the effect of utilizing VR on reducing opioid use in study participants undergoing mastectomy with implant-based reconstruction compared to the control group. Investigators will follow patients throughout the course of their hospitalization and monitor outcomes including pain levels, medication requests, and satisfaction.

Eligible participants will receive a VR headset and instructed to use the VR every time they feel pain and before asking for a pain medication. They can take pain medications, if they choose to do so. At their post-op visit, study participants will be interviewed and asked questions regarding their experience with VR.

Pain level and medication use will be compared with similar individuals who undergo the same procedure but are not provided with a VR headset.

Inclusion Criteria:

• Age ≥ 18 years
• Women who plan to undergo mastectomy and implant-based reconstruction
• Written informed consent obtained from subject and ability for subject to comply with the requirements of the study.
• Able to read and comprehend English

Exclusion Criteria:

• Current diagnosis of epilepsy, dementia, or other neurologic disease that may prevent use of VR headset and software
• Sensitivity to flashing light
• Diagnosis of motion sickness
• Pregnancy or a medical condition where the study participant is prone to frequent nausea or dizziness
• Current or recent (less than 6 months) use of opioids
• Individuals with psychiatric disorders, including those with delirium or other disorders that may involve hallucinations or psychosis